Vik Malik
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Vik Malik
Chief Commercialisation Officer / Proteomics International Laboratories
Vik Malik has over 20 years of experience in the life sciences and healthcare industries, as a commercialisation expert and business strategy advisor for several multinational growth-stage and startup medical device & diagnostics companies.
He has been involved in the launch of numerous disruptive medical technologies, cutting-edge biotherapies, innovative healthcare IT solutions, and customised business process outsourcing services to penetrate new & emerging markets.
Mr Malik has a Bachelor of Science (Marketing) from Southern Illinois University and is based in the US.
He has been involved in the launch of numerous disruptive medical technologies, cutting-edge biotherapies, innovative healthcare IT solutions, and customised business process outsourcing services to penetrate new & emerging markets.
Mr Malik has a Bachelor of Science (Marketing) from Southern Illinois University and is based in the US.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 536th | Proteomics International Laboratories | 8% | 26% |
| 1155th | BauMart Holdings | -29% | -19% |
| 1277th | icetana | -37% | |
| 1501st | Carnegie Clean Energy | -52% | -20% |
| 1657th | Sprintex | -63% | -28% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 136th |  | Proteomics International Laboratories | $3.2m |
| 146th | | BauMart Holdings | $2.2m |
| 147th |  | Carnegie Clean Energy | $2.2m |
| 149th | | icetana | $1.9m |
| 150th | | Sprintex | $1.9m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Chief Commercialisation Officer, Proteomics International Laboratories | 10 Jun 2021 |
